Parallel Advisors’s Gilead Sciences GILD Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$3.91M Buy
35,231
+1,067
+3% +$118K 0.08% 175
2025
Q1
$3.83M Sell
34,164
-2,876
-8% -$322K 0.09% 169
2024
Q4
$3.42M Sell
37,040
-2,258
-6% -$209K 0.08% 185
2024
Q3
$3.29M Sell
39,298
-18,825
-32% -$1.58M 0.08% 191
2024
Q2
$3.99M Buy
58,123
+12,349
+27% +$847K 0.1% 152
2024
Q1
$3.35M Buy
45,774
+2,438
+6% +$179K 0.09% 167
2023
Q4
$3.51M Buy
43,336
+207
+0.5% +$16.8K 0.1% 151
2023
Q3
$3.23M Sell
43,129
-1,421
-3% -$106K 0.11% 149
2023
Q2
$3.43M Buy
44,550
+404
+0.9% +$31.1K 0.11% 148
2023
Q1
$3.66M Buy
44,146
+1,908
+5% +$158K 0.12% 143
2022
Q4
$3.63M Sell
42,238
-2,389
-5% -$205K 0.16% 99
2022
Q3
$2.75M Buy
44,627
+7,680
+21% +$474K 0.13% 114
2022
Q2
$2.28M Buy
36,947
+1,488
+4% +$92K 0.1% 131
2022
Q1
$2.12M Buy
35,459
+2,205
+7% +$132K 0.08% 159
2021
Q4
$2.42M Buy
33,254
+2,255
+7% +$164K 0.09% 149
2021
Q3
$2.17M Buy
30,999
+1,657
+6% +$116K 0.09% 161
2021
Q2
$2.02M Buy
29,342
+2,335
+9% +$161K 0.09% 161
2021
Q1
$1.75M Buy
27,007
+821
+3% +$53K 0.08% 173
2020
Q4
$1.53M Sell
26,186
-450
-2% -$26.2K 0.08% 166
2020
Q3
$1.68M Sell
26,636
-1,801
-6% -$114K 0.1% 145
2020
Q2
$2.19M Buy
28,437
+363
+1% +$27.9K 0.14% 111
2020
Q1
$2.1M Buy
28,074
+3,005
+12% +$225K 0.17% 96
2019
Q4
$1.63M Sell
25,069
-1,276
-5% -$82.9K 0.12% 133
2019
Q3
$1.67M Buy
26,345
+150
+0.6% +$9.51K 0.14% 122
2019
Q2
$1.77M Buy
26,195
+607
+2% +$41K 0.17% 104
2019
Q1
$1.66M Sell
25,588
-116
-0.5% -$7.54K 0.19% 99
2018
Q4
$1.61M Sell
25,704
-6,138
-19% -$384K 0.22% 84
2018
Q3
$2.46M Buy
31,842
+25,900
+436% +$2M 0.31% 60
2018
Q2
$420K Sell
5,942
-1,173
-16% -$82.9K 0.06% 208
2018
Q1
$536K Sell
7,115
-178
-2% -$13.4K 0.08% 174
2017
Q4
$522K Buy
7,293
+208
+3% +$14.9K 0.09% 166
2017
Q3
$516K Buy
7,085
+147
+2% +$10.7K 0.09% 161
2017
Q2
$528K Buy
6,938
+2,014
+41% +$153K 0.1% 156
2017
Q1
$331K Sell
4,924
-4,244
-46% -$285K 0.07% 207
2016
Q4
$657K Buy
+9,168
New +$657K 0.15% 113